Market Research Report

Global Cholera Vaccines Market Report By Product (Dukoral, Shanchol, Vaxchora, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11214337
April 2021
Report Formats: Report Formats
Global Cholera Vaccines Market Overview
The key driver impacting the cholera vaccine market is the rising prevalence of cholera cases globally. The growing cholera incidence, particularly in developing nations, is likely to create the need for its prevention, thus creating demand for cholera vaccines demand in the forecast period. for instance, according to WHO, in 2017, each year, 1.3 to 4.0 million cholera cases are reported, and 21,000 to 143,000 deaths occur globally. In 2015, cholera caused around 172,454 cases were reported, with 1304 deaths occurred in 42 countries. moreover, lack of clean water and proper sanitation increases the risk of people developing the disease, thus support the demand for vaccination against the disease, thus contributing to market growth.
According to Value Market Research, the global cholera vaccine market size was valued at around USD 70 million in 2020 and is projected to grow at a CAGR of about 8% during the forecast period 2021 to 2027.

The global coverage of immunization and government initiatives to reduce cholera incidences across the globe is estimated to augment cholera vaccines demand in the forecast period. as per the World Health Organisation, a survey conducted in 2014 estimated that about 3,175 206 doses of Dukoral and Shanchol were deployed in vaccination campaigns worldwide between 1997 and 2014. a more significant number of doses was utilized in affected areas; vaccines are still underused considering 1.4 billion people who are at risk. according to WHO, most of the doses produced since 2013 have entered the stockpile, which has increased from approximately two million per year during 2013–2014 to seven million in 2016, with 17 million anticipated in 2017 and over 25 million from 2018 onwards. the global regulatory authorities are taking the considerable initiative to minimize cholera by providing immunization. for instance, a global strategy on cholera control, Ending Cholera: a global roadmap to 2030, was launched in 2017 with an aim to decrease cholera deaths by 90%. Similarly, in partnership with UNICEF, Kenya had implemented the Multi-Sectoral Cholera Prevention and Control Plan (MCPCP) for 2011 to 2016 to avert the disease. Moreover, in December 2012, the United Nations announced Haiti and the Dominican Republic's initiative to eliminate the disease. however, the adverse effects of vaccines may hamper the global cholera vaccine market in the long run. also, high costs associated with the development of vaccines are negatively impacting the market. the current industry trends, such as the rising government support for immunization programs, and the development of new approaches for novel cholera vaccine, are expected to provide market players with new market opportunities.

The cholera vaccine market is vast, with many local and global players. the cholera vaccine market is extensive, with many local and international players. the key leaders follow different strategies to advance their market position, such as amalgamation, contracts, extending product portfolio, product upgrades, and acquisitions, to augment their market share across the globe. The significant players studied in the report are Sanofi Emergent Biosolutions, Inc., Valneva SE, Astellas Pharma Inc., GlaxoSmithKline LLC, Astellas Pharma Inc.

Global Cholera Vaccines Market Share

In this research report, the cholera vaccine market is segmented by product and region.

Analysis by Product:
By product, the report is segmented into the dukoral, shanchol, vaxchora, and others. The Dukoral dominates the product segment with a 70% share in 2020. It is due to its established stockpile of OCV by WHO. Also, the vaccine offers protection against diarrhea caused by heat-labile-toxin-generating E. coli. Moreover, the rising number of travelers to low- and middle-income countries (LMICs) drives demands for dukoral products in the forecast period.

Analysis by Region:
In the regional outlook of the global cholera vaccines market, the Europe and Asia Pacific region together dominate with over 55% market share during the forecast period. It is due to the increasing incidence of cholera and the growing importance of immunization across the Asia Pacific region. Moreover, the rising awareness programs and high availability of efficient preventive solutions contribute to the high demand for the cholera vaccines market in Europe and Asia pacific.
 
Market Segmentation covered in the Report:
By Product 
  • Dukoral
  • Shanchol
  • Vaxchora
  • Others
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.   

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . CHOLERA VACCINES – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Product
           3.7.2 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL CHOLERA VACCINES MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Dukoral Market by Regions
       6.5 Shanchol Market by Regions
       6.6 Vaxchora Market by Regions
       6.7 Others Market by Regions
 
7 . GLOBAL CHOLERA VACCINES MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview, Historic and Forecast Data
           7.3.2. North America By Segment
           7.3.3. North America By Country
           7.3.4. United State
           7.3.5. Canada
           7.3.6. Mexico
       7.4. Europe
           7.4.1. Overview, Historic and Forecast Data
           7.4.2. Europe by Segment
           7.4.3. Europe by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7. Italy
           7.4.8. Russia
           7.4.9. Rest Of Europe
       7.5. Asia Pacific
           7.5.1. Overview, Historic and Forecast Data
           7.5.2. Asia Pacific by Segment
           7.5.3. Asia Pacific by Country
           7.5.4. China
           7.5.5. India
           7.5.6. Japan
           7.5.7. South Korea
           7.5.8. Australia
           7.5.9. Rest Of Asia Pacific
       7.6. Latin America
           7.6.1. Overview, Historic and Forecast Data
           7.6.2. Latin America by Segment
           7.6.3. Latin America by Country
           7.6.4. Brazil
           7.6.5. Argentina
           7.6.6. Peru
           7.6.7. Chile
           7.6.8. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview, Historic and Forecast Data
           7.7.2. Middle East & Africa by Segment
           7.7.3. Middle East & Africa by Country
           7.7.4. Saudi Arabia
           7.7.5. UAE
           7.7.6. Israel
           7.7.7. South Africa
           7.7.8. Rest Of Middle East And Africa
 
8 . COMPETITIVE LANDSCAPE OF THE CHOLERA VACCINES COMPANIES
       8.1. Cholera Vaccines Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF CHOLERA VACCINES INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Sanofi Emergent Biosolutions, Inc.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Valneva SE, Astellas Pharma Inc.
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. GlaxoSmithKline LLC
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Astellas Pharma Inc.
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product  (USD MN)
  •  Dukoral Market by Geography (USD MN)
  •  Shanchol Market by Geography (USD MN)
  •  Vaxchora Market by Geography (USD MN)
  •  Others Market by Geography (USD MN)
  •  Global Cholera Vaccines Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Cholera Vaccines Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Cholera Vaccines Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product  (USD MN)
  •  Dukoral Market by Geography (USD MN)
  •  Shanchol Market by Geography (USD MN)
  •  Vaxchora Market by Geography (USD MN)
  •  Others Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials